SUNNYVALE, Calif., July 27, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY) ("Accuray") today announced the pricing of its offering of $100 million aggregate principal amount of 3.75% convertible senior notes due 2016 (the "notes").
SUNNYVALE, Calif., July 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY) ("Accuray") today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2016 (the "notes"), to
Adoption Demonstrates Continued Demand for Dedicated Whole Body Stereotactic Radiosurgery Systems at World's Most Renowned Cancer Centers SUNNYVALE, Calif., July 25, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today
SUNNYVALE, Calif., July 20, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, will host a symposium examining best practices for quality assurance in radiation oncology at the 2011 Joint American Association of Physicists in Medicine
Research points to ability of these technologies to extend treatment options for a wide range of lung cancer patients SUNNYVALE, Calif., July 7, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced new clinical data highlighting the
San Francisco Bay Area Innovators Gather to Discuss the Economic Impact on Local Healthcare Companies SUNNYVALE, Calif., June 24, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiation oncology, today hosted a roundtable discussion on the
SUNNYVALE, Calif., June 16, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, offering best-in-class technologies to fight cancer, announced today that its management is scheduled to present at the Wells Fargo 2011 Healthcare Conference in
Transaction Combines Best-in-Class Technologies and Industry-Leading Talent to Create the Premier Radiation Oncology Company SUNNYVALE, Calif., June 13, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it has completed its previously announced acquisition of
SUNNYVALE, Calif., June 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated (Nasdaq: TOMO) by Accuray.
SUNNYVALE, Calif., May 19, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson , Ph.D., is scheduled to present at Jefferies' 2011 Global Healthcare
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
